StonvexLoading…
StonvexStonvexStonvexCore line items from ALT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2021 2021-12-31 | Annual 2020 2020-12-31 | Annual 2019 2019-12-31 | Annual 2018 2018-12-31 |
|---|---|---|---|---|
Revenue | $4.41M | $8.19M | $5.80M | $10.33M |
Operating Income | $-96.91M | $-54.80M | $-21.46M | $-42.83M |
Net Income | $-97.09M | $-49.04M | $-20.52M | $-39.17M |
EPS (Diluted) | $-2.35 | $-1.91 | Not available | Not available |
Total Assets | $218.87M | $245.12M | $54.06M | $54.75M |
Total Liabilities | $19.73M | $19.24M | $8.54M | $6.44M |
Cash & Equivalents | $190.30M | $115.92M | $8.96M | $33.72M |
Free Cash Flow OCF − CapEx | $-90.36M | $-34.51M | $-9.60M | $-10.36M |
Shares Outstanding | 40.99M | 37.14M | 15.31M | 9.08M |